Fulltext

Correction to: A multicentre, multi-national, double-blind, randomised, active-controlled, parallel-group clinical study to assess the safety and efficacy of PDA10 (Epoetin-Alfa) vs. Eprex® in patients with anaemia of chronic renal failure

Lim SK 1 , Goh BL 2 , Visvanathan R 3 , Kim SH 4 , Jeon JS 5 , Kim SG 6 Show all authors , Chang JH 7 , Lim CS 8 , Morad Z 9

Affiliations 

  • 1 Renal Division, Department of Medicine, Faculty of Medicine, University of Malaya, 59100, Kuala Lumpur, Malaysia. limsk@ummc.edu.my
  • 2 Serdang Hospital, Kajang, Malaysia
  • 3 Prince Court Medical Centre, Kuala Lumpur, Malaysia
  • 4 Chung-Ang University Hospital, Seoul, South Korea
  • 5 Soonchunhyang University Hospital, Seoul, South Korea
  • 6 Hallym University Sacred Heart Hospital, Anyang, South Korea
  • 7 Gil Medical Centre, Gachon University College of Medicine, Incheon, South Korea
  • 8 Seoul National University Boramae Medical Centre, Seoul, South Korea
  • 9 KPJ Ampang Puteri Specialist Hospital, Ampang, Malaysia
BMC Nephrol, 2022 Jan 03;23(1):14.
PMID: 34979969 DOI: 10.1186/s12882-021-02651-0

* Title and MeSH Headings from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Similar publications